Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS

Background: Progressive disseminated histoplasmosis (PDH) is an important cause of mortality in persons living with HIV (PLHIV), especially in countries where patients have limited access to antiretroviral therapies and diagnostic testing. Objective: A lateral flow assay (LFA) to detect Histoplasma...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2020
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/22635
Acceso en línea:
https://doi.org/10.1111/myc.13023
https://repository.urosario.edu.co/handle/10336/22635
Palabra clave:
Fungus antigen
Histoplasma capsulatum antigen
Unclassified drug
Aids patient
Antigen detection
Article
Colombian
Controlled study
Cross reaction
Diagnostic accuracy
Diagnostic test accuracy study
Histoplasma capsulatum
Histoplasmosis
Human
Immunoassay
Lateral flow assay
Major clinical study
Priority journal
Progressive disseminated histoplasmosis
Sensitivity and specificity
South american blastomycosis
Rights
License
Abierto (Texto Completo)
id EDOCUR2_6c3860c31ed705d9b602dcd288125744
oai_identifier_str oai:repository.urosario.edu.co:10336/22635
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling f6526ca4-0523-4cfd-8bbb-b718335fbc78-11598a9c7-daee-42c6-83bf-7ddb0e350ad6-1213a6448-bdcb-4c33-bc60-5a903cca22c8-1cb82302e-5b4a-4608-899d-d11563e87da7-176ba161b-7e7f-4a03-8d25-664389d9da66-12020-05-25T23:57:14Z2020-05-25T23:57:14Z2020Background: Progressive disseminated histoplasmosis (PDH) is an important cause of mortality in persons living with HIV (PLHIV), especially in countries where patients have limited access to antiretroviral therapies and diagnostic testing. Objective: A lateral flow assay (LFA) to detect Histoplasma capsulatum antigen in serum developed by MiraVista® was evaluated. Methods: We tested 75 serum samples: 24 from PLHIV and culture-proven PDH and 51 from PLHIV with other fungal and bacterial infections as well as people without HIV. LFA devices were read manually (read by eye) and by an automated reader. Results: When the LFA was read manually, sensitivity was 96% and specificity was 90%. When an automated reader was used, sensitivity was 92% and specificity was 94%. The Kappa index comparing manual and automated reader was 0.90. Cross-reactions were observed principally in samples from patients with proven diagnosis of paracoccidioidomycosis. Conclusions: The MiraVista® Diagnostics Histoplasma antigen LFA had high analytical performance and good agreement between manual and automated reader. This LFA allows Histoplasma antigen testing with minimal laboratory equipment and infrastructure requirements. © 2019 Blackwell Verlag GmbHapplication/pdfhttps://doi.org/10.1111/myc.130230933740714390507https://repository.urosario.edu.co/handle/10336/22635engBlackwell Publishing Ltd144No. 2139MycosesVol. 63Mycoses, ISSN:09337407, 14390507, Vol.63, No.2 (2020); pp. 139-144https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075746317&doi=10.1111%2fmyc.13023&partnerID=40&md5=b99e820176b72a088575a2cc7552a84bAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURFungus antigenHistoplasma capsulatum antigenUnclassified drugAids patientAntigen detectionArticleColombianControlled studyCross reactionDiagnostic accuracyDiagnostic test accuracy studyHistoplasma capsulatumHistoplasmosisHumanImmunoassayLateral flow assayMajor clinical studyPriority journalProgressive disseminated histoplasmosisSensitivity and specificitySouth american blastomycosisEvaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDSarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Cáceres, Diego H.Gómez, Beatriz L.Tobón, Angela M.Chiller, Tom M.Lindsley, Mark D.10336/22635oai:repository.urosario.edu.co:10336/226352022-05-02 07:37:14.278479https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS
title Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS
spellingShingle Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS
Fungus antigen
Histoplasma capsulatum antigen
Unclassified drug
Aids patient
Antigen detection
Article
Colombian
Controlled study
Cross reaction
Diagnostic accuracy
Diagnostic test accuracy study
Histoplasma capsulatum
Histoplasmosis
Human
Immunoassay
Lateral flow assay
Major clinical study
Priority journal
Progressive disseminated histoplasmosis
Sensitivity and specificity
South american blastomycosis
title_short Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS
title_full Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS
title_fullStr Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS
title_full_unstemmed Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS
title_sort Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS
dc.subject.keyword.spa.fl_str_mv Fungus antigen
Histoplasma capsulatum antigen
Unclassified drug
Aids patient
Antigen detection
Article
Colombian
Controlled study
Cross reaction
Diagnostic accuracy
Diagnostic test accuracy study
Histoplasma capsulatum
Histoplasmosis
Human
Immunoassay
Lateral flow assay
Major clinical study
Priority journal
Progressive disseminated histoplasmosis
Sensitivity and specificity
South american blastomycosis
topic Fungus antigen
Histoplasma capsulatum antigen
Unclassified drug
Aids patient
Antigen detection
Article
Colombian
Controlled study
Cross reaction
Diagnostic accuracy
Diagnostic test accuracy study
Histoplasma capsulatum
Histoplasmosis
Human
Immunoassay
Lateral flow assay
Major clinical study
Priority journal
Progressive disseminated histoplasmosis
Sensitivity and specificity
South american blastomycosis
description Background: Progressive disseminated histoplasmosis (PDH) is an important cause of mortality in persons living with HIV (PLHIV), especially in countries where patients have limited access to antiretroviral therapies and diagnostic testing. Objective: A lateral flow assay (LFA) to detect Histoplasma capsulatum antigen in serum developed by MiraVista® was evaluated. Methods: We tested 75 serum samples: 24 from PLHIV and culture-proven PDH and 51 from PLHIV with other fungal and bacterial infections as well as people without HIV. LFA devices were read manually (read by eye) and by an automated reader. Results: When the LFA was read manually, sensitivity was 96% and specificity was 90%. When an automated reader was used, sensitivity was 92% and specificity was 94%. The Kappa index comparing manual and automated reader was 0.90. Cross-reactions were observed principally in samples from patients with proven diagnosis of paracoccidioidomycosis. Conclusions: The MiraVista® Diagnostics Histoplasma antigen LFA had high analytical performance and good agreement between manual and automated reader. This LFA allows Histoplasma antigen testing with minimal laboratory equipment and infrastructure requirements. © 2019 Blackwell Verlag GmbH
publishDate 2020
dc.date.accessioned.none.fl_str_mv 2020-05-25T23:57:14Z
dc.date.available.none.fl_str_mv 2020-05-25T23:57:14Z
dc.date.created.spa.fl_str_mv 2020
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1111/myc.13023
dc.identifier.issn.none.fl_str_mv 09337407
14390507
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/22635
url https://doi.org/10.1111/myc.13023
https://repository.urosario.edu.co/handle/10336/22635
identifier_str_mv 09337407
14390507
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 144
dc.relation.citationIssue.none.fl_str_mv No. 2
dc.relation.citationStartPage.none.fl_str_mv 139
dc.relation.citationTitle.none.fl_str_mv Mycoses
dc.relation.citationVolume.none.fl_str_mv Vol. 63
dc.relation.ispartof.spa.fl_str_mv Mycoses, ISSN:09337407, 14390507, Vol.63, No.2 (2020); pp. 139-144
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-85075746317&doi=10.1111%2fmyc.13023&partnerID=40&md5=b99e820176b72a088575a2cc7552a84b
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Blackwell Publishing Ltd
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167543427891200